Dynamic contrast-enhanced MRI with subtraction of aggressive soft tissue tumors after resection

Skeletal Radiology

Volumn 27, Issue 9, 1998, Pages 505-510

  Vanel, Daniel ^a,b   Shapeero, Lorraine G ^b,c,d   Tardivon, Anne ^a,b   Western, André ^e   Guinebretière, Jean Marc ^b  

^a Ctr Inter Etablissement Reson M   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e NYCOMED IMAGING AS   (Norway)

Author keywords

Contrast medium (MRI); Dynamic study (MRI); Follow up; MRI; Soft tissue tumors

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BOLUS INJECTION; ELECTRON SPIN RESONANCE; FEMALE; FOLLOW UP; HUMAN; IMAGE SUBTRACTION; INTRAVENOUS ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSEUDOTUMOR; RECURRENT DISEASE; SOFT TISSUE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SOFT TISSUE NEOPLASMS; SUBTRACTION TECHNIQUE;

EID: 0031714644     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002560050428     Document Type: Article

References (22)

1. Enzinger FM, Weiss SW. Soft tissue tumors, 3rd edn. Washington, DC: CV Mosby, 1995.
2. Vanel D, Shapeero LG, De Baere T, et al. MR imaging in the follow up of malignant and aggressive soft tissue tumors: results of 511 examinations. Radiology 1994; 190: 263-268.
3. De Baere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, Di Paola M. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology 1992; 185: 587-592.
4. Heywang-Köbrunner SH, Viehweg P, Heinig A, Küchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997; 24 : 94-108.
5. Mirowitz SA. Fast scanning and fat-suppression MR imaging of musculoskeletal disorders. AJR 1993; 161:1147.
6. Mirowitz SA, Apicella P, Reinus WR, et al. MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images. AJR 1993; 162: 215.
7. Pui MH, Chang SK. Comparison of inversion recovery fast spin-echo (FSE) with T2-weighted fat-saturated FSE and T1-weighted MR imaging in bone marrow lesion detection. Skeletal Radiol 1996; 25: 149.
8. Weinberger E, Shaw DW, White KS, et al. Nontraumatic pediatric musculoskeletal MR imaging: comparison of conventional and fast-spin-echo short inversion time inversion-recovery technique. Radiology 1995; 194: 721.
9. Vanel D, Lacombe MJ, Couanet D, Kalifa C, Spielmann M, Genin J. Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology 1987; 164: 243-245.
10. Glazer HS, Lee JK, Levitt RJ. Radiation fibrosis: differentiation from recurrent tumor by MR imaging. Radiology 1985; 756: 721-726.
11. Ebner F, Kressel HY, Mintz MC, et al. Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T. Radiology 1988; 166: 333.
12. McVicar AD, Oliff JFC, Pringle J, Pinkerton CR, Husband JES. Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation. Radiology 1992; 184: 859.
13. Sundaram M, McGuire MH, Schajowicz F. Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images. AJR 1987; 148: 1247-1250.
14. Panicek DM, Schwanz LH, Heelan RT, et al. Non-neoplastic causes of high signal intensity at T2-weighted MR imaging after treatment for musculoskeletal neoplasm. Skeletal Radiol 1995; 24: 185.
15. Hawnaur JM, Johnson RJ, Isherwood I, Jenkins JPR. Gd-DTPA in MRI of bladder carcinoma. In: Katayama H, Brasch RC, eds. New dimensions of contrast media. New York: Elsevier, 1991: 357-363.
16. Sundaram M, Baran G, Merenda G, McDonald DJ. Myxoid liposarcoma: MRI appearances with clinical and histological correlation. Skeletal Radiol 1990; 19: 359-362.
17. Erlemann R, Reiser MF, Peters PE, et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989; 171: 767-773.
18. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 1992; 184: 243.
19. Erlemann R. Dynamic gadolinium-enhanced MR imaging to monitor tumor response to chemotherapy (letter). Radiology 1993; 186: 904.
20. Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Di Paola R. Factor analysis of dynamic MR imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 1992; 27: 847-855.
21. Verstraete KL, Dierick A, De Deene Y, et al. First-pass images of musculoskeletal lesions: a new and useful diagnostic application of dynamic contrast-enhanced MRI. Magn Reson Imaging 1994; 12: 687-702.
22. Vanel D, Verstraete KL, Shapeero LG. Primary tumors of the musculo-skeletal system. Radiol Clin North Am 1997; 35: 213-237.